WhiteLab Genomics

Paris, France

WhiteLab Genomics develops digital tools that help gene and cell therapy companies develop cheaper drugs faster.

Sep 2022

Seed

Artificial Intelligence (AI)Biotechnology Genetics

Top Investors

Y CombinatorOmnes CapitalDebiopharm Group

Founder Contacts

19,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about WhiteLab Genomics

Who are WhiteLab Genomics's investors?

WhiteLab Genomics's investors include Y Combinator, Omnes Capital, Debiopharm Group.

Where is WhiteLab Genomics headquartered?

WhiteLab Genomics is headquartered in Paris, France.

What does WhiteLab Genomics do?

WhiteLab Genomics develops digital tools that help gene and cell therapy companies develop cheaper drugs faster.

What stage is WhiteLab Genomics at?

WhiteLab Genomics is at the Seed stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated September 12, 2022.

MLA

"WhiteLab Genomics — Funding & Investors." VCBacked, September 12, 2022, https://www.vcbacked.co/company/whitelab-genomics. Accessed July 1, 2026.

APA

VCBacked. (2022). WhiteLab Genomics — Funding & Investors. Retrieved July 1, 2026, from https://www.vcbacked.co/company/whitelab-genomics

Wikipedia (cite web)

{{cite web |title=WhiteLab Genomics — Funding & Investors |url=https://www.vcbacked.co/company/whitelab-genomics |website=VCBacked |access-date=July 1, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated September 12, 2022.

Similar Companies in Artificial Intelligence (AI)